Lantheus (NASDAQ:LNTH) reported what management described as a strong start to 2026, citing solid performance from its three core commercial products—PYLARIFY, Neuraceq® and DEFINITY—and progress...
Lantheus (NASDAQ:LNTH) Surprises With Q1 CY2026 Sales
Lantheus Holdings: Q1 Earnings Snapshot
Strong start to the year with worldwide revenue of $377.3 million in the first quarter 2026 GAAP fully diluted earnings per share of $1.80, compared to $1.02 in the first quarter of 2025 Adjusted fully...
Barchart Research What to Expect from LNTH Earnings LNTH Generated May 6, 2026 Current Price $86.15 EPS Estimate $$1.02 Consensus Rating Strong Buy Average Move 14.51% Lantheus Defied Estimates for Two...
Lantheus (LNTH) Q1 Earnings Report Preview: What To Look For
BEDFORD, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday,...
1 Healthcare Stock to Target This Week and 2 We Ignore
